Sae Rin Jean

1.0k total citations
11 papers, 845 citations indexed

About

Sae Rin Jean is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sae Rin Jean has authored 11 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Cancer Research. Recurrent topics in Sae Rin Jean's work include ATP Synthase and ATPases Research (5 papers), Mitochondrial Function and Pathology (3 papers) and RNA Interference and Gene Delivery (3 papers). Sae Rin Jean is often cited by papers focused on ATP Synthase and ATPases Research (5 papers), Mitochondrial Function and Pathology (3 papers) and RNA Interference and Gene Delivery (3 papers). Sae Rin Jean collaborates with scholars based in Canada, Italy and United States. Sae Rin Jean's co-authors include Shana O. Kelley, Simon Wisnovsky, Eric K. Lei, Marya Ahmed, David V. Tulumello, Aaron D. Schimmer, Mark P. Pereira, Libing Zhang, Edward H. Sargent and Sharif Ahmed and has published in prestigious journals such as Nature Communications, Nano Letters and Accounts of Chemical Research.

In The Last Decade

Sae Rin Jean

11 papers receiving 843 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sae Rin Jean Canada 11 580 231 149 131 80 11 845
Eric K. Lei Canada 8 437 0.8× 179 0.8× 165 1.1× 69 0.5× 35 0.4× 12 693
Amy B. Foraker United States 12 450 0.8× 137 0.6× 151 1.0× 67 0.5× 149 1.9× 13 792
Nicole D. Barth United Kingdom 17 461 0.8× 278 1.2× 220 1.5× 68 0.5× 73 0.9× 28 1.1k
N. Sukumar United States 15 504 0.9× 84 0.4× 180 1.2× 96 0.7× 38 0.5× 35 827
Irene Galiana Spain 11 381 0.7× 248 1.1× 182 1.2× 63 0.5× 59 0.7× 12 764
Sriram S. Shanmugavelandy United States 17 542 0.9× 363 1.6× 165 1.1× 210 1.6× 94 1.2× 21 1.0k
Katharine L. Diehl United States 10 614 1.1× 166 0.7× 149 1.0× 32 0.2× 78 1.0× 18 966
Yiru Wang China 11 284 0.5× 193 0.8× 133 0.9× 133 1.0× 35 0.4× 20 535
Sijun Pan Singapore 17 654 1.1× 191 0.8× 97 0.7× 44 0.3× 107 1.3× 30 976
Swati Biswas United States 7 424 0.7× 233 1.0× 86 0.6× 273 2.1× 33 0.4× 10 658

Countries citing papers authored by Sae Rin Jean

Since Specialization
Citations

This map shows the geographic impact of Sae Rin Jean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sae Rin Jean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sae Rin Jean more than expected).

Fields of papers citing papers by Sae Rin Jean

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sae Rin Jean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sae Rin Jean. The network helps show where Sae Rin Jean may publish in the future.

Co-authorship network of co-authors of Sae Rin Jean

This figure shows the co-authorship network connecting the top 25 collaborators of Sae Rin Jean. A scholar is included among the top collaborators of Sae Rin Jean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sae Rin Jean. Sae Rin Jean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Schroeder, Mark A., Mark A. Fiala, Michael H. Cardone, et al.. (2019). A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma. Clinical Cancer Research. 25(13). 3776–3783. 12 indexed citations
2.
Huang, Shar-yin N., Ilaria Dalla Rosa, David V. Tulumello, et al.. (2018). Mitochondrial tyrosyl‐ DNA phosphodiesterase 2 and its TDP 2 S short isoform. EMBO Reports. 19(3). 19 indexed citations
3.
Zhang, Libing, Sae Rin Jean, Xiyan Li, et al.. (2018). Programmable Metal/Semiconductor Nanostructures for mRNA-Modulated Molecular Delivery. Nano Letters. 18(10). 6222–6228. 39 indexed citations
4.
Zhang, Libing, Sae Rin Jean, Sharif Ahmed, et al.. (2017). Multifunctional quantum dot DNA hydrogels. Nature Communications. 8(1). 381–381. 136 indexed citations
5.
Buondonno, Ilaria, Elena Gazzano, Sae Rin Jean, et al.. (2016). Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma. Molecular Cancer Therapeutics. 15(11). 2640–2652. 83 indexed citations
6.
Wisnovsky, Simon, Eric K. Lei, Sae Rin Jean, & Shana O. Kelley. (2016). Mitochondrial Chemical Biology: New Probes Elucidate the Secrets of the Powerhouse of the Cell. Cell chemical biology. 23(8). 917–927. 70 indexed citations
7.
Jean, Sae Rin, Marya Ahmed, Eric K. Lei, Simon Wisnovsky, & Shana O. Kelley. (2016). Peptide-Mediated Delivery of Chemical Probes and Therapeutics to Mitochondria. Accounts of Chemical Research. 49(9). 1893–1902. 208 indexed citations
8.
Wisnovsky, Simon, et al.. (2016). Mitochondrial DNA repair and replication proteins revealed by targeted chemical probes. Nature Chemical Biology. 12(7). 567–573. 79 indexed citations
9.
Jean, Sae Rin, et al.. (2015). Mitochondrial Targeting of Doxorubicin Eliminates Nuclear Effects Associated with Cardiotoxicity. ACS Chemical Biology. 10(9). 2007–2015. 63 indexed citations
10.
Jean, Sae Rin, Mark P. Pereira, & Shana O. Kelley. (2014). Structural Modifications of Mitochondria-Targeted Chlorambucil Alter Cell Death Mechanism but Preserve MDR Evasion. Molecular Pharmaceutics. 11(8). 2675–2682. 20 indexed citations
11.
Jean, Sae Rin, David V. Tulumello, Simon Wisnovsky, et al.. (2014). Molecular Vehicles for Mitochondrial Chemical Biology and Drug Delivery. ACS Chemical Biology. 9(2). 323–333. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026